Study Reveals Persistent Tissue Changes in Ulcerative Colitis Despite Clinical Healing
Researchers analyzing tissue from 89 ulcerative colitis patients found that mucosal healing — the standard clinical endpoint — does not reflect complete biological recovery, as persistent stromal cell reprogramming remains detectable. The study used a combination of single-cell transcriptomics, spatial profiling, and multiplexed imaging to map cellular changes across disease states. The findings suggest current remission criteria may miss underlying vulnerability to relapse and could point toward new biomarkers for predicting treatment response.
A preprint study posted to bioRxiv constructed a detailed multimodal atlas of ulcerative colitis (UC) tissue by integrating several high-resolution genomic and imaging techniques across 89 patients. The researchers found that even in patients classified as achieving mucosal healing — the primary benchmark used in clinical trials and practice — the intestinal lining retains significant stromal abnormalities along three distinct axes: the emergence of inflammatory fibroblasts, a sustained loss of OGN-expressing niche-supporting fibroblasts, and an expansion of pericytes with matrix-remodeling activity and reduced vascular association. Spatial profiling confirmed that the organization of mucosal tissue domains remained disrupted despite apparent clinical remission. Importantly, the inflammatory fibroblast and pericyte signatures detected at baseline were found to robustly predict which patients would not respond to anti-TNF therapy, a widely used class of UC treatments, across independent patient cohorts. The authors conclude that mucosal healing represents a biologically distinct and incomplete recovery state, and that stromal reprogramming may be a key driver of disease persistence and therapeutic failure in UC.
What's missing
As a preprint, this study has not yet undergone peer review. Long-term follow-up data linking stromal signatures to actual relapse events in these patients is not described. The authors do not address whether the identified stromal changes are reversible with existing or emerging therapies.
What different sources said
- bioRxivCenter
Persistent stromal reprogramming defines incomplete mucosal healing and predicts therapeutic response in ulcerative colitis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.